Catalyst Wire Dossier Catalyst Wire Dossier

PROVENGE

sipuleucel-T · Dendreon
Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for PROVENGE, covering 2010-09-06 to 2025-08-27. Get the full timeline:

Most recent: Clinical Trial Update: Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T [Phase 2]

See pricing